Skip to main content
Clinical Trials/NCT07215338
NCT07215338
Completed
Not Applicable

Understanding and Mitigating Delayed Onset Muscle Soreness (DOMS)

Stanford University1 site in 1 country22 target enrollmentStarted: June 28, 2024Last updated:

Overview

Phase
Not Applicable
Status
Completed
Enrollment
22
Locations
1
Primary Endpoint
Mean change from baseline in phosphorylation markers in the Janus kinase/signal transducer and activator of transcription (JAK/STAT) and Toll-like Receptor (TLR)-pathway in immune cell populations

Overview

Brief Summary

This is a research study on human exercise that will investigate the immune system response post-exercise and how it relates to Delayed Onset Muscle Soreness (DOMS), and possible causes for DOMS.

Blood draws (10mL) will be obtained at 5 timepoints: Baseline before intervention, day of exercise immediately following exercise, and post-exercise days 1, 2 and 4.

Point of care lactate levels obtained before and after exercise.

Subjective pain scores recorded daily starting immediately after after exercise.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Basic Science
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • \- Ability to perform two arm bicep curl of at least 35 lb as 1 repetition maximum

Exclusion Criteria

  • Autoimmune disease
  • Steroid use
  • On current immune-modifying treatment

Outcomes

Primary Outcomes

Mean change from baseline in phosphorylation markers in the Janus kinase/signal transducer and activator of transcription (JAK/STAT) and Toll-like Receptor (TLR)-pathway in immune cell populations

Time Frame: From enrollment to 5 days after the end of treatment

Collected at baseline from whole blood prior to exercise, day of exercise, post-exercise day 1, post-exercise day 2, post-exercise day 4

Secondary Outcomes

  • Change from pre-exercise baseline in point of care lactate levels(1 day)
  • Change in Pain Scores from baseline(From day of intervention daily for 5 days.)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

H Craig Heller

Professor

Stanford University

Study Sites (1)

Loading locations...

Similar Trials